Showing 1 - 10 of 2,521
This paper examines the idea that the USA has outshined Europe in the race for new medicines as a result of a flight of business R&D expenditure to the USA. It adopts a methodology that accounts for R&D price inflation, considers the role of both ‘performed' R&D and ‘extra-mural' R&D, and...
Persistent link: https://www.econbiz.de/10013155663
supportive evidence for pharmaceuticals. This study revisits this hypothesis using OECD data for the period 1980-2000. It extends …
Persistent link: https://www.econbiz.de/10013155664
Persistent link: https://www.econbiz.de/10012242700
Persistent link: https://www.econbiz.de/10011708133
Persistent link: https://www.econbiz.de/10012800211
identifying and eliminating import dependencies in the field of pharmaceuticals. HERA’s work thus aligns with current EU efforts …
Persistent link: https://www.econbiz.de/10013540432
As health care reform evolves and takes shape, comparative effectiveness research appears to be one of the central topics on the national health care agenda. Over the past couple of years, comparative effectiveness has been explicitly incorporated in over ten bills. For example, the passage of...
Persistent link: https://www.econbiz.de/10013094926
Persistent link: https://www.econbiz.de/10000331527
Persistent link: https://www.econbiz.de/10003317153
Persistent link: https://www.econbiz.de/10003691595